Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-435-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- according to OECD and GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- Principles of method if other than guideline:
- Based on a “Statement on the Scientific Validity of In Vitro Tests for Skin Irritation” of the European Commission (November 2008), official acceptance of the test method in the EU was achieved and implemented in EU, 2008a, Council Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to EC Regulation No 1907/2006 of the European Parliament and of the Council on REACH; 1st ATP 2009: EC Regulation No 761/2009 of 23 July 2009 amending, for the purpose of its ATP, EC Regulation No 440/2008 laying down test methods pursuant to EC Regulation No 1907/2006 of the European Parliament and of the Council on REACH, section B46.
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Aluminium tris(5,7,12,14-tetrahydro-7,14-dioxoquino[2,3-b]acridine-2-sulphonate)
- EC Number:
- 278-207-2
- EC Name:
- Aluminium tris(5,7,12,14-tetrahydro-7,14-dioxoquino[2,3-b]acridine-2-sulphonate)
- Cas Number:
- 75431-69-5
- Molecular formula:
- C20H12N2O5S.1/3Al
- IUPAC Name:
- aluminum tris(7,14-dioxo-5,7,12,14-tetrahydroquino[2,3-b]acridine-2-sulfonate)
- Reference substance name:
- 5,12-dihydroquino[2,3-b]acridine-7,14-dione
- EC Number:
- 213-879-2
- EC Name:
- 5,12-dihydroquino[2,3-b]acridine-7,14-dione
- Cas Number:
- 1047-16-1
- Molecular formula:
- C20H12N2O2
- IUPAC Name:
- 5,12-dihydroquino[2,3-b]acridine-7,14-dione
- Reference substance name:
- Dialuminium tris(5,7,12,14-tetrahydro-7,14-dioxoquino[2,3-b]acridine-2,9-disulphonate)
- EC Number:
- 243-319-2
- EC Name:
- Dialuminium tris(5,7,12,14-tetrahydro-7,14-dioxoquino[2,3-b]acridine-2,9-disulphonate)
- Cas Number:
- 19795-24-5
- Molecular formula:
- C20H12N2O8S2.2/3Al
- IUPAC Name:
- dialuminium tris(5,7,12,14-tetrahydro-7,14-dioxoquino[2,3-b]acridine-2,9-disulphonate)
Constituent 1
Constituent 2
Constituent 3
In vitro test system
- Test system:
- human skin model
- Vehicle:
- other: DPBS (MatTek)
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 25 µL bulk volume (~ 17 mg)
- Duration of treatment / exposure:
- Three EpiDerm tissues were incubated with the test substance for 1 hour followed by a 42 hours post-incubation period
- Duration of post-treatment incubation (if applicable):
- 42 hours
- Number of replicates:
- 3
Test animals
- Species:
- other: reconstituted human epidermis model
Test system
- Type of coverage:
- other: Topical
- Preparation of test site:
- other: Not applicable
- Vehicle:
- other: DPBS (MatTek)
- Controls:
- yes
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit):
Each approximately 25 µL bulk volume (~ 17 mg) of the test item were applied to the tissues, wetted with 25 µL DPBS, and spread to match the surface of the tissue for a complete treatment time of 60 minutes.
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 30 µL DPBS (MatTek) were used as negative control and negative control KC per tissue.
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 30 µL of a 5 % SLS solution in deionised water (MatTek) were used as positive control per tissue.- Duration of treatment / exposure:
- 1 hour followed by a 42 hours post-incubation period
- Observation period:
- Not applicable
- Number of animals:
- Not applicable
- Details on study design:
- The test is based on the experience that irritant chemicals produce cytotoxicity in human reconstructed epidermis after a 1 hour topical exposure and about 42 hours post-incubation. The test is designed to predict skin irritation potential of a chemical by using the three dimensional human epidermis model EpiDermTM. After application of the test material to the stratum corneum surface of the tissue the induced cytotoxicity (= loss of viability) is measured in a colometric assay. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity. The mitochondrial dehydrogenase reduces the yellow colored water-soluble 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) to the insoluble blue colored formazan. After isopropanol-extraction of the formazan from the tissues, the optical densitiy of the extract is determined spectrophotometrically. Optical density of the extracts of test-substance treated tissues is compared to values from negative control (NC) tissues and expressed as relative tissue viability.
The EpiDermTM model (EPI-200) consists of normal, human-derived epidermal keratinocytes which have been cultured to form a multi layered, hight differentiated model of the human epidermis. It consists of organized basal, spinous and granular layers arranged in patterns analogous to those found in vivo. used to model the human corneal epithelium. The EpiDermTM tissues (surface 0.6 cm2) are cultured on cell culture inserts (MILLICELLsR, diameter 10 mm) and are commercially available as kits (EpiDermTM 200), containing 24 tissues on shipping agarose.
Tissue model: EPI-200
Lot number: 23377
Supplier: MatTek In Vitro Life Science Laboratories, Bratislava, Slovakia
On the day of arrival the tissues were transferred to sterile 6-well plates with 0.9 mL assay medium and preconditioned in the incubator at 37°C. After 1 hour the pre-incubation medium was replaced with fresh medium and preconditioning continued for 18 ± 3 hours.
Three tissues were treated with the test substance, the positive and negative control respectively. In addition three killed tissues were used for the test substance and the negative control respectively in order to detect direct MTT reduction.
25 µL sterile DPBS was applied first. Therafter a bulk volume of 25 µL of the test substance was applied and distributed together with the fluid.
Control tissues were concurrently applied with 30 µL of sterile DPBS (NC, NC KC) or with 30 µL of 5 % SLS (PC) or test substance (KC). A nylon mesh was placed carefully onteh the tissue surface afterwards.
The tissues were washed with sterile DPBS to remove residual test material 1 hour after start of application.
Rinsed tissues were blotted on sterile absorbent paper and transferred iinto new 6-well plates, pre-filled with 0.9 mL fresh medium. When all tissues were rinsed, the surface of each tissue was carefully dried with a sterile cotton swab.
Subsequently the tissues were incubated in the incubated at 37°C for 24 ± 2 hours. Then the tissues were transferred into new 6-well plates pre-filled with 0.9 nL of fresh medium and placed into the incubator for additional 18 ± 2 hours post-incubation period. After the post-incubation period, the assay medium was replaced by 0.3 mL MTT solution and the tissues were incubated for 3 hours. Thereafter the tissues were wahsed with DPBS to stop the MTT-incubation. the formazan that was metabolically produced by the tissues was extracted by incubation of the tissues in isopropanol.
The optical densitiy at a wavelength of 570 nm (OD570) of the extracts was determined spectrophotometrically. Blank values were established of 4 microtiter wells filled with isopropanol fro each microtiter plate.
The OD570 values determined for the various tissues are measures of their viability. The quotient of the OD570 of tissues treated with the test substance and the mean OD570 values of the NC is used for evaluating whether a test substance is irritant or not irritant.
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- mean viability of tissues after KC correction
- Value:
- 99.6
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
Any other information on results incl. tables
Findings:
substance |
|
|
tissue 1 |
tissue 2 |
tissue 3 |
mean |
standard deviation |
coefficient of variation [%] |
negative control |
viable tissues |
mean OD570 |
1.802 |
1.693 |
1.695 |
1.730 |
|
|
viability [% of NC] |
104.2 |
97.9 |
98.0 |
100.0 |
3.6 |
3.6 |
||
KC tissues |
mean OD570 |
0.051 |
0.053 |
0.047 |
0.050 |
|
|
|
viability [% of NC] |
2.9 |
3.1 |
2.7 |
2.9 |
0.2 |
6.6 |
||
positive control |
viable tissues |
mean OD570 |
0.041 |
0.055 |
0.051 |
0.049 |
|
|
viability [% of NC] |
2.4 |
3.2 |
2.9 |
2.8 |
0.4 |
14.3 |
||
test substance |
viable tissues |
mean OD570 |
1.541 |
1.746 |
1.895 |
1.727 |
|
|
|
viability [% of NC] |
89.0 |
100.9 |
109.5 |
99.8 |
10.3 |
10.3 |
|
|
KC tissues |
mean OD570 KC NC corrected |
0.004 |
0.007 |
0.003 |
0.005 |
|
|
|
viability [% of NC] |
0.2 |
0.4 |
0.2 |
0.3 |
0.1 |
45.1 |
|
|
final mean viability of tissues after KC correction [% of NC] |
99.6 |
|
|
Due to the ability of the test substance to reduce MTT directly, KC tissues were applied in parallel. The results of the KC tissues indicate an increased MTT reduction (mean viability 0.3 % NC). thus for the test substance the final mean viability is given after KC correction.
The
data show, that a treatment with the test item did not significantly
affect the viability of tissues (relative viabilty = 99.6 %)
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Regulation (EC) 1272/2008
- Conclusions:
- In conclusion, it can be stated that in this study and under the experimental conditions reported, the test item is not irritant to skin according to Regulation (EC) 1272/2008.
- Executive summary:
The potential of the test substance to cause dermal irritaion was assessed by single topical application of ca. 25 µL bulk volume (about 17 mg) of the undiluted test substance to a reconstructed three dimensional human epidermis model (EpiDermTM).
Three EpiDermTM tissues were incubated with the test substance for 1 hour followed by a 42 -hours post-incubation period.
Tissue destruction was determined by measuring the metabolic activity of the tissue after exposure/post-incubation using a colorimetric test. The reduction ot mitochondrial dehydrogenase activity, measured by reduced formazan production after incubation with a tetrazolium salt (MTT) was chosen as endpoint. The formazan production of the test substance treated epidermal tissues was compared to that of negative control tissues. The quotient of both values indicated the realtive tissue viability.
The following test results were obtained:
The test substance was able to reduce MTT directly. Therefore an additional MTT reduction control KC (freeze-killed control tissues) was introduced.
In a pre-test it was demonstraed that the color of the test substance did not interfere with the colorimetric test.
The mean viability of the test substance treated tissues determined after an exposure period of 1 hour with about 42 hours post-incubation was 99.6 %. All acceptance criteria were met.
Thus, the test substance does not show a skin irritation potential in the EpiDermTM in vitro skin irritation test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.